CGP 6809 — A new nitrosoureido-sugar derivative with activity in human tumor xenografts Heinz H. FiebigKarl H. WidmerGeorg W. Löhr Original Articles Pages: 337 - 340
CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties Klaus SchieweckJaroslav StanekAlex Matter Original Articles Pages: 341 - 347
Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesis Michael A. CornbleetAndrew KingsnorthJohn F. Smyth Original Articles Pages: 348 - 352
Accumulation of tetrahydrofolates in human plasma after leucovorin administration Marlene A. BunniBarbara M. RembiesaRobert Stuart Original Articles Pages: 353 - 357
Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine William N. HaitSteve MorrisPeter E. Schwartz Original Articles Pages: 358 - 362
A comparison of regional versus systemic drug injection Fang-Ku P'engChew-Wun WuWing-Yiu Lui Original Articles Pages: 363 - 366
Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma David R. NewellRosalind A. EelesA. Hilary Calvert Original Articles Pages: 367 - 372
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide Martin GoreRay PowlesFulvio Porta Original Articles Pages: 373 - 376
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support William P. PetersAnn StuartJoseph O. Moore Original Articles Pages: 377 - 383
Treatment of adult acute lymphoblastic leukaemia using an intensive chemotherapy protocol R. LiangT. K. ChanD. Todd Original Articles Pages: 384 - 388
GR38032F, a 5HT3 receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting Michel MartyJean P. DrozJacques Bons Original Articles Pages: 389 - 391
Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia Imtiaz ChoonaraJohn WheeldonIan Lewis Short Communication Pages: 392 - 394
Effect of cancer chemotherapy on dapsone N-acetylation in man P. A. PhilipP. G. HarperH. J. Rogers Short Communication Pages: 395 - 396
Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients? James CassidyDavid J. KerrStanley B. Kaye Short Communication Pages: 397 - 400
Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults Sarah M. DonohueBrian J. Boughton Short Communication Pages: 401 - 402